Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-24-043462

Options or other derivatives

  • Chief Financial Officer acquired 146,544 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pamir Ozan · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-10-21 Grant or award : show line 1 in the form Employee Stock Options (right to buy) +146,544 146,544 D
Loading xslF345X05/wk-form4_1729717442.xml…